For example, MAPT is the most differentially expressed gene as a function of response to preoperative Paclitaxel treatment in breast cancer [63], whereby low TAU mRNA predicted complete response to taxanes, as confirmed also in additional studies [85,89]. This evidence concerns the gene MAPT and breast cancer.